NHF Medical and Scientific Advisory Council (MASAC) met during NHF's 69th Annual Meeting on August 26, 2017 in Chicago. Three new documents were developed as a result of the meeting. The new documents were adopted by NHF's Board of Directors on September 17, 2017:
MASAC Document #250: MASAC Recommendations Concerning Products Licensed for the Treatment of Hemophilia and Other Bleeding Disorders
MASAC Document #251: MASAC Guidelines for Perinatal Management of Women with Bleeding Disorders and Carriers of Hemophilia A and B.
MASAC Document #252: Guidelines for Emergency Department Management of Individuals with Hemophilia and Other Bleeding Disorders.
Visit https://www.hemophilia.org/Newsroom/Medical-News/MASAC-Issues-Three-New-Documents to read the full recommendations and guidelines. To request a hard copy of any current documents, please contact HANDI, NHF's information resource center: [email protected] or 1.800.424.2634
